weekly question 14/6/2026

[Admin]

A term infant is born with a congenital chylothorax. The neonatal team places a chest tube and begins an octreotide infusion. The parents inquire about the safety of this medication. The most common clinical adverse event in infants receiving an octreotide infusion is:

a Intraventricular hemorrhage

b Necrotizing enterocolitis

c Seizures

d Hypotension requiring vasopressors

e Symptomatic hypoglycemia

 

[Hassan k]

A term infant is born with a congenital chylothorax. The neonatal team places a chest tube and begins an octreotide infusion. The parents inquire about the safety of this medication. The most common clinical adverse event in infants receiving an octreotide infusion is:

a Intraventricular hemorrhage

b Necrotizing enterocolitis

c Seizures

d Hypotension requiring vasopressors

e Symptomatic hypoglycemia

E

 

[Abd El wahed]

E

 

[Tsakane]

A term infant is born with a congenital chylothorax. The neonatal team places a chest tube and begins an octreotide infusion. The parents inquire about the safety of this medication. The most common clinical adverse event in infants receiving an octreotide infusion is:

a Intraventricular hemorrhage

b Necrotizing enterocolitis

c Seizures

d Hypotension requiring vasopressors

e Symptomatic hypoglycemia

B

 

[CATHERINECOR]

E

 

[Qadir M.Salih]

D

 

[Kawtar surg]

A term infant is born with a congenital chylothorax. The neonatal team places a chest tube and begins an octreotide infusion. The parents inquire about the safety of this medication. The most common clinical adverse event in infants receiving an octreotide infusion is:

a Intraventricular hemorrhage

b Necrotizing enterocolitis

c Seizures

d Hypotension requiring vasopressors

e Symptomatic hypoglycemia

d

 

[Admin]

correct answer
d Hypotension requiring vasopressors

Octreotide has been used in a number of clinical conditions in infants. Most commonly chylothorax, hypoglycemia and gastrointestinal hemorrhage. A 2015 study of 428 infants over 15 years at 333 neonatal ICUs demonstrated that laboratory abnormalities were relatively common, particularly thrombocytopenia (47/1000 infant days), hyperkalemia (21/1000) and leukocytosis (20/1000). Hyper and hypoglycemia were rare. The most common clinical adverse event was hypotension requiring pressor support (12%). NEC complicated 2% of cases and death occurred in 3 %.